RALEIGH, N.C., June 19, 2008 (PRIME NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), a development stage pharmaceutical company engaged in the acquisition of promising therapeutic drug candidates and advancing their clinical development for later sale or license, announced the appointment of Geert Cauwenbergh, PhD, to its Board of Directors. The appointment was effective June 14, 2008 and fills a vacancy that had previously existed on the company’s Board.
